Close Menu

Save the Devils!

In a paper published online in advance in PNAS this week, the Pennsylvania State University's Stephan Schuster and his international colleagues report their whole-genome analysis of two animals of distinct geographic origin, as well as 14 complete mitochondrial genomes from both current and museum specimens, for the Tasmanian devil — which continues to face the threat of "extinction because of a contagious cancer known as Devil Facial Tumor Disease," the authors write.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.